Manufacturer record
Medirin Pharmaceuticals Pvt. Ltd. - 408 HSIIDC: regulatory record
Last checked 10 October 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Medirin Pharmaceuticals Pvt. Ltd. - 408 HSIIDC were declared Not of Standard Quality between August 2026 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Medirin Pharmaceuticals Pvt. Ltd. - 408 HSIIDC in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | T250249Mfg 2025-04 · Exp 2027-03 | The sample does not conform to prescribed standard, in respect of DisintegrationDisintegration | LUCKNOW LABState lab | Aug 2026 |
| Olmesartan Medoxomil Tablets IP | T250250Mfg 2025-05 · Exp 2027-04 | The sample does not conform to IP, in respect of Description, Dissolution & Assay.Assay | LUCKNOW LABState lab | Aug 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.